ACT-ED: Accessibility and Feasibility of an Acceptance and Commitment Therapy (ACT)-Based Eating Disorder Prevention Program

June 5, 2025 updated by: Emine Serra Nebati, Ibn Haldun University

ACT-ED: ACT-Based Eating Disorder Prevention Program

The goal of this clinical trial is to investigate the accessibility and feasibility of an online group prevention program developed for women at risk for eating disorders. Also, to conduct a preliminary analysis of treatment efficacy. The main questions it aims to answer are:

Does ACT-ED an acceptable intervention for women at risk for eating disorders? Does intervention result in reduced eating pathology?

Participants will:

Join the online, 4-session ACT-based group program Fill the measures at Pre-test, post-test and follow-up assessment

Study Overview

Study Type

Interventional

Enrollment (Actual)

5

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Basaksehir
      • Istanbul, Basaksehir, Turkey, 34480
        • Ibn Haldun University Psychotherapy Application and Research Center (IPAM)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being a woman aged 18 years or older
  • Exhibiting disordered eating behaviors (EDE-Q score ≥ 3.03)
  • Experiencing body dissatisfaction (BSQ-34 score ≥ 110)

Exclusion Criteria:

  • Current or past diagnosis/treatment for an eating disorder
  • Currently receiving psychotherapy
  • Currently receiving psychiatric medication (not excluded if there has been no change in treatment in the last 6 months)
  • Having chronic psychiatric disorders (e.g. psychosis)
  • Having a substance addiction

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Group intervention
ACT-based online group intervention. 4 sessions of 1.5 hours, held once a week

This intervention protocol was developed specifically for women who have body dissatisfaction and disordered eating behaviors. Based on the psychological flexibility model (hexaflex), it is designed to improve people's body image flexibility using Acceptance and Commitment Therapy techniques.

Interventions related to the dimensions of the hexaflex were made during each session. The first session covers values and goal setting. The second session includes creative hopelessness, acceptance, and self-compassion. The third session covers defusion and mindfulness. The last session focuses on self-as-context exercises and the combined use of skills for committed action.

Other Names:
  • ACT-ED

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disordered eating, assessed by the Turkish form of the Eating disorder examination questionnaire (EDE-Q)
Time Frame: Baseline (pretest), week 4(posttest), 1-month follow-up
Disordered eating is a risk factor for eating disorders. In a prevalence study conducted in Türkiye, individuals with EDE-Q scores of 3.03 and above were defined as a high-risk group (Deveci, 2020). In this study, EDE-Q scores were assessed for inclusion criteria during enrollment. Additionally, changes in EDE-Q scores are assessed at post-test and follow-up to assess treatment effect.
Baseline (pretest), week 4(posttest), 1-month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body dissatisfaction, assessed by the Turkish form of Body shape Questionnaire (BSQ)
Time Frame: Baseline (pretest), week 4(posttest), 1-month follow-up
A total score of the questionnaire can be in the range of 34 to 204 where total score lower than 110 represents no concern, a total score between 110 and 137 represents mild concern, a total score between 138 and 166 represents moderate concern, and a total score higher than 167 represent severe concern. In this study, EDE-Q scores were assessed for inclusion criteria during enrollment; participants scores of 110 and above are included. Additionally, changes in EDE-Q scores are assessed at post-test and follow-up.
Baseline (pretest), week 4(posttest), 1-month follow-up
Body image flexibility, assessed by the Turkish form of the Body Image Acceptance and Action Questionnaire (BI-AAQ)
Time Frame: Baseline (pretest), week 4(posttest), 1-month follow-up
Body image flexibility (BIF) is a construct derived from the psychological flexibility model. BIF is defined as the capacity to experience perceptions, sensations, feelings, thoughts, and beliefs related to one's body without avoidance while acting in alignment with personal values. The BI-AAQ consists of 12 items; higher scores indicate lower BIF and increased body image inflexibility. In this study, this scale would be used to assess how one's relation with body image-related internal experiences changes after the prevention program.
Baseline (pretest), week 4(posttest), 1-month follow-up
Psychological flexibility, assessed by Acceptance and Action Questionnaire (AAQ-II)
Time Frame: Baseline (pretest), week 4(posttest), 1-month follow-up
The AAQ-II is designed to assess psychological flexibility defined as the capacity to be in contact with the present moment, fully aware of one's thoughts, emotions, and sensations. Higher scores indicate decreased psychological flexibility and increased experiential avoidance. In this study, the scale was used to assess changes in the general psychological flexibility.
Baseline (pretest), week 4(posttest), 1-month follow-up
Present moment awareness, assessed by the Turkish form of the Freiburg Mindfulness Inventory (FMI)
Time Frame: Baseline (pretest), week 4(posttest), 1-month follow-up
Present moment awareness is one of the dimensions of the psychological flexibility model. It is defined as the ability to fully engage with the present moment. Higher scores indicate better present moment awareness. In future studies, it is desired to examine which dimension of the psychological flexibility model has an effect on the treatment outcome. In this study, FMI was used to test its suitability in measuring change in this intervention.
Baseline (pretest), week 4(posttest), 1-month follow-up
Contextual Self, assessed by the Turkish form of the Self-As-Context Scale (SACS)
Time Frame: Baseline (pretest), week 4(posttest), 1-month follow-up
Contextual Self is one of the dimensions of the psychological flexibility model. It is defined as one's ability to view himself with a broader perspective. Higher scores indicate improved contextual self. In future studies, it is desired to examine which dimension of the psychological flexibility model has an effect on the treatment outcome. In this study, SACS was used to test its suitability in measuring change in this intervention.
Baseline (pretest), week 4(posttest), 1-month follow-up
Defusion, assessed by the Turkish form of the Cognitive Fusion Scale (CFS)
Time Frame: Baseline (pretest), week 4(posttest), 1-month follow-up
Defusion is one of the dimensions of the psychological flexibility model. It is defined as one's ability to separate himself from his thoughts. Higher scores indicate fusion, which is the opposite of defusion. In future studies, it is desired to examine which dimension of the psychological flexibility model has an effect on the treatment outcome. In this study, SACS was used to test its suitability in measuring change in this intervention.
Baseline (pretest), week 4(posttest), 1-month follow-up
Personality beliefs, assessed by the Turkish form of the Personality Beliefs Questionnaire- Short Form (PBQ-SF)
Time Frame: Baseline (pretest), week 4(posttest), 1-month follow-up

Obsessive-compulsive personality disorder and borderline personality disorder are the most common personality disorders in eating disorders. PBQ is designed to assess dysfunctional personality beliefs, and higher scores on a subscale indicate stronger dysfunctional beliefs related to the corresponding personality.

In future studies, it is desired to examine how the personality beliefs are affected by the prevention program. In this study, PBQ-SF was used to test its suitability in measuring change in personality beliefs by this intervention.

Baseline (pretest), week 4(posttest), 1-month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emine Serra Nebati, Ibn Haldun University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 18, 2024

Primary Completion (Actual)

February 2, 2025

Study Completion (Actual)

February 2, 2025

Study Registration Dates

First Submitted

April 11, 2025

First Submitted That Met QC Criteria

April 20, 2025

First Posted (Actual)

April 25, 2025

Study Record Updates

Last Update Posted (Actual)

June 10, 2025

Last Update Submitted That Met QC Criteria

June 5, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024/09-08

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to confidentiality concerns and ethical considerations.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disordered Eating Behaviors

Clinical Trials on ACT based eating disorder prevention program

Subscribe